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Background: Autogenous arteriovenous fistula (AVF) is the best vascular access (VA) for hemodialysis, but its
creation is still a critical procedure. Physical examination, vascular mapping and doppler ultrasound (DUS)
evaluation are recommended for AVF planning, but they can not provide direct indication on AVF outcome. We
recently developed and validated in a clinical trial a patient-specific computational model to predict pre-operatively
the blood flow volume (BFV) in AVF for different surgical configuration on the basis of demographic, clinical and
DUS data. In the present investigation we tested power of prediction and usability of the computational model in
routine clinical setting.
Methods: We developed a web-based system (AVF.SIM) that integrates the computational model in a single
procedure, including data collection and transfer, simulation management and data storage. A usability test on
observational data was designed to compare predicted vs. measured BFV and evaluate the acceptance of the
system in the clinical setting. Six Italian nephrology units were involved in the evaluation for a 6-month period that
included all incident dialysis patients with indication for AVF surgery.
Results: Out of the 74 patients, complete data from 60 patients were included in the final dataset. Predicted
brachial BFV at 40 days after surgery showed a good correlation with measured values (in average 787 ± 306
vs. 751 ± 267 mL/min, R = 0.81, p < 0.001). For distal AVFs the mean difference (±SD) between predicted vs.
measured BFV was −2.0 ± 20.9%, with 50% of predicted values in the range of 86–121% of measured BFV.
Feedbacks provided by clinicians indicate that AVF.SIM is easy to use and well accepted in clinical routine,
with limited additional workload.
Conclusions: Clinical use of computational modeling for AVF surgical planning can help the surgeon to
select the best surgical strategy, reducing AVF early failures and complications. This approach allows
individualization of VA care, with the aim to reduce the costs associated with VA dysfunction, and to
improve AVF clinical outcome.
Keywords: Arteriovenous fistula, Computational modeling, Surgical planning, Hemodialysis vascular access* Correspondence: andrea.remuzzi@marionegri.it
1Department of Biomedical Engineering, IRCCS-Istituto di Ricerche
Farmacologiche “Mario Negri”, Bergamo, Italy
9Department of Management, Information and Production Engineering,
University of Bergamo, Bergamo, Italy
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Bozzetto et al. BMC Medical Informatics and Decision Making  (2017) 17:26 Page 2 of 9Background
Autogenous arteriovenous fistula (AVF) is the best
choice for providing an efficient and long-lasting vas-
cular access (VA) for hemodialysis (HD) patients, but
it still has low primary and secondary patency rate
[1]. The goal of AVF surgery is to obtain a blood flow
volume (BFV) that allows a flow rate of at least
300 mL/min of blood within the HD extracorporeal
circulation. On the other hand very high BFV, ex-
ceeding 1.5 L/min, should be avoided, for the risk for
cardiac dysfunction and hand ischemia [2]. Vascular
access dysfunction and complications such as non-
maturation, failure, hand ischemia and risk of heart
failure are important open clinical challenges [3].
There is a general consensus that careful planning of
VA in end-stage renal disease patients approaching
renal replacement therapy by HD is of crucial import-
ance. Thus, patient physical examination, vascular
mapping and Doppler ultrasound (DUS) evaluation of
vessels are recommended for AVF planning [4, 5].
These procedures can suggest if patient vasculature
structure and function are adequate for creation of a
native fistula or if potential problems may develop
during or after AVF surgery. However, they cannot
provide an indication to the surgeon on the real out-
come of the planned anastomosis in terms of AVF
blood flow that will be obtained after the process of
vessel remodeling and the consequent maturation of
the VA. An objective and reliable prediction of post-
operative BFV over time could be extremely import-
ant for planning the optimal AVF configuration. This
information, if available, could guide the surgeon in
the choice of location and type of anastomosis. Actu-
ally, it would be useful to know pre-operatively if
BFV is predicted to be too low or too high, suggest-
ing the risk of non-maturation of VA or risk for
cardiac failure, respectively.
We have previously reported that a computational
model [6], inserted in an open-source numerical solver
[7], for prediction of AVF outcome, was successfully used
to simulate clinical data obtained by expert clinical centers
during a controlled clinical trial [8, 9]. The result of the
computation allows to predict the effect of an AVF anasto-
mosis type (end-to-side, end-to-end or side-to-side) and
location (upper, middle or lower arm) in terms of changes
in BFV, arterial and venous diameters that develop during
AVF maturation, the process in which the artery and the
vein importantly remodel to accommodate the increase in
BFV resulting from direct connection of the arterial circu-
lation to the vein. The tool has been validated in a pro-
spective, observational and multicenter clinical study [9].
On the basis of these results the aim of our investigation
was to develop and validate a system that allows using the
computational tool in clinical practice.The use of new technology in the clinical setting, and
especially for computational modeling, needs careful
evaluation of their effective usability and potential bene-
fit in this critical environment. There are some import-
ant aspects that have to be considered in this regard.
Firstly, clinical routine data generated may be not as
accurate as those generated within a controlled clinical
study. Secondly, a new tool should not increase the
workload of the clinicians that is lately continuing
increasing. With these constrains, we developed a web-
based system (AVF.SIM) for simple and easy data trans-
fer and fast and effective consultation of predicted
results on planned AVF outcome. We then monitored
six clinical centers during the use of the system in the
routine clinical practice. We used observational pre- and
post-operative clinical data to compare predicted BFVs
with measured post-operative data. In addition, we




The computer code we used in our investigation is based
on a pulse wave propagation network model (0D/1D) of
the circulation previously developed [10, 11]. Briefly, in
the vascular network segments and nodes are connected
on the basis of main anatomical configuration. Each
segment is modeled with an electric circuit using hy-
draulic analogy and model solution is based on the com-
putation of hydraulic pressure and BFV for each element
from conservation of mass and momentum, by assuming
fully developed incompressible Newtonian blood flow in
a straight tube. For each element three parameters are
defined: hydraulic resistance and inductance per unit
length, and vessel compliance, that incorporates the
storage capacity of the segment. Changes in venous
compliance, as a function of pressure, were derived from
clinical data reported in literature [12]. Blood flow in
side branches is taken into account using end-segments
with linear resistance and a non-linear element is used
for simulation of the hemodynamics in AVF anasto-
mosis. As regards boundary conditions, cardiac output is
assumed according to cardiac index [13], while extravas-
cular pressure is assumed equal to 0 mmHg.
As previously described [13], patient-specific vascular
networks are obtained on the basis of a generic vascular
network model derived from literature data [14], adapt-
ing geometrical vessel diameters and lengths according
to body weight, height, age and sex of individual patient.
Blood vessel wall elasticity was also adapted according to
demographic and clinical data (presence of hypertension
and diabetes).
To estimate changes in vessel dimensions and BFV in-
duced by AVF maturation, the solver embeds a vascular
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on the assumption that vessel dilation takes place
upon changes in BFV to maintain physiologic value
of the peak wall shear stress acting on vascular endo-
thelial cells [15].
The AVF.SIM system
With the aim of introducing the computational model in
the clinical setting, we developed the AVF.SIM system
based on the flow of information represented in Fig. 1.
As previously described [11], the first step of the proced-
ure was the collection of demographic and clinical data
in patients in need of AVF creation. Demographic data
consist of patient age, gender, height and weight. Clinical
data included haematocrit, plasma protein concentra-
tion, presence or absence of diabetes and/or hyperten-
sion. Subsequently, pre-operative DUS examination data
were collected, including arterial and venous measure-
ments according to the protocol described in detail
below. Demographic information, clinical data and DUS
measurements were collected by anonymized fillable
.pdf form, where the nephrologist or the vascular sur-
geon also specifies the type and location of AVF they se-
lected for surgery.
These pre-operative and anonymized forms were then
sent by email to the Simulation Centre (Mario Negri In-
stitute) and used for computer-based simulations. The
results of the simulation were obtained in approximately
half an hour. An output report (.pdf format) was then
generated with computed time changes of BFV and di-
ameters of arteries and veins (in selected locations) from
the pre-operative condition up to 40 days after surgery,
the typical time period in which AVF maturation takesFig. 1 Representation of AVF.SIM system showing the procedure,
that includes data collection and transfer, simulation management
and data storing. Abbreviations: DUS, doppler ultrasound;
AVF, arteriovenous-fistulaplace (see Additional file 1). These reports were then
transmitted back to the clinicians by email and also
made available through a secured web-based document
management system (DMS), a repository for quick
visualization of files protected by personal login. The
users have restricted access to data of their own clinical
centre only.
Usability test of the AVF.SIM system
To evaluate the acceptance of AVF.SIM system in the
clinical setting, a usability test with duration of 6 months
was designed. Data were collected on the basis of
routine clinical management of patients in need of VA
to start renal replacement therapy by HD. Data on all
incident dialysis patients selected for a native AVF in the
observation period were considered, whereas data from
patients designated for central venous catheter or syn-
thetic arteriovenous graft were excluded from the present
test. The following six centres took part to the test: ASST-
Papa Giovanni XXIII (Bergamo), Ospedale F. Miulli
(Acquaviva delle Fonti, Bari), Ospedale Civile S. Spirito
(Pescara), Azienda Ospedaliera Cannizzaro (Catania),
Azienda Ospedaliera di Cosenza-Annunziata (Cosenza),
Policlinico Universitario A. Gemelli (Rome). The local Eth-
ics Committee of coordinating center approved the study
protocol. Consent for the use of clinical data was obtained
from each patient before AVF surgery. Clinical data have
been derived from routine patient records and no inter-
vention was based on data generated during the usability
test. Ten interventional nephrologists with several years of
expertise in VA management, including pre-operative
mapping, surgery and surveillance, were introduced to the
system sharing the vascular protocol and instructions for
data collection and transmission. All the nephrologists
belong to the Vascular Access Working Group of the
Italian Society of Nephrology.
As shown in Fig. 2, 74 patients were selected for enrol-
ment in the study. All patients underwent clinical and
vascular DUS examinations pre-operatively. For two
patients AVF was not created due to very small blood
vessel diameter. In 11 patients, AVF was created in the
upper arm and was brachio-cephalic (BC). In 61 patients
AVF was created in the lower arm and it was radio-
cephalic (RC). The type of anastomosis was side-to-end
(7 BC and 39 RC), end-to-end (14 RC) or side-to-side
(9 RC and 3 BC).
For the comparison of computational prediction and
the effective outcome of AVF surgery, a follow-up DUS
examination was performed 40 days after surgery.
Follow-up data on access BVF were inserted in an anon-
ymized fillable.pdf form, transferred to the Simulation
Centre using the same procedure used for pre-operative
data. Out of the 72 patients, 40-day follow-up data were
not provided in only one patient. Eleven patients were
Fig. 2 Flow diagram showing the number of patients selected for
AVF.SIM usability test and the number of them included in the
final dataset
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sistent follow-up BFV measurements, mainly for brachial
artery BFV lower than the sum of radial and ulnar artery
BFV (Fig. 2). Demographic and clinical data, used to
generate patient-specific vascular network models of theTable 1 Demographic and clinical data
RC S-E RC E
Number of AVF 32 13
Age (years) 60 ± 16 62 ±
Gender (females) 13 (41%) 0 (0
AVF arm (right) 8 (25%) 1 (8
Height (cm) 168 ± 11 170
Weight (kg) 75 ± 18 75 ±
Systolic Pressure (mmHg) 136 ± 17 145
Diastolic Pressure (mmHg) 76 ± 9 82 ±
Hematocrit (%) 33 ± 5 34 ±
Protein plasma concentration (g/dl) 6.5 ± 0.7 6.8 ±
Hypertension (yes) 25 (78%) 11 (
Diabetes (yes) 6 (18%) 1 (8
Values are mean ± s.d. for continuous variables or frequency (percentage) for gende
Abbreviations: AVF arterio-venous fistula, BC brachio-cephalic, RC radio-cephalic, E-Epatients included in the final dataset, are summarized in
Table 1. At the end of AVF.SIM usability test, a ques-
tionnaire was submitted to all clinicians, to measure
their satisfaction and to collect suggestions for further
development of the system and the user interface (see
Additional file 2). All users were asked to fill in a ques-
tionnaire with twelve statements, using a level of agree-
ment between 1 and 5, corresponding to the following
scale: 1 = strongly disagree, 2 = disagree, 3 = not agree
nor disagree, 4 = agree, 5 = strongly agree. To measure
the satisfaction level, for every statement the mean of
the score was calculated.
Protocol for vascular DUS evaluations
During the pre-operative DUS examination patients
were in a standardized supine position with the exam-
ined arm parallel to the body in a comfortable position
for imaging. Both for arterial and for venous side, diame-
ters were assessed using B-mode images of vessels in
their transverse view and consisted of short- and long-
axis diameter measurements. Venous assessment in-
cluded cephalic vein from the wrist to the cephalic arch,
the cubital vein at the elbow, the basilic vein from the
elbow until it joins the brachial vein in the upper arm
and the subclavian vein immediately before the bifur-
cation of the cephalic arch and basilic vein. These
measurements of venous vessels were assessed making
use of a proximal pressure-cuff for congestion. Arterial
assessment included brachial artery at middle-arm and
at the elbow, radial and ulnar arteries both in the middle
and distal positions and subclavian artery. For the mea-
surements of subclavian artery and subclavian vein the
patient was asked to hold his breath. On brachial, radial
and ulnar artery the time average velocity (TAV) was
also assessed. The operator was required to trace three-E RC S-S BC S-E BC S-S
5 7 3
15 67 ± 15 57 ± 14 72 ± 11
%) 0 (0%) 6 (86%) 3 (100%)
%) 1 (20%) 1 (14%) 1 (33%)
± 9 168 ± 3 166 ± 7 158 ± 3
12 72 ± 8 61 ± 9 68 ± 11
± 19 124 ± 18 139 ± 13 133 ± 15
14 74 ± 17 80 ± 6 83 ± 6
3 34 ± 5 36 ± 4 39 ± 1
0.6 6.5 ± 0.5 6.8 ± 0.7 6.3 ± 0.4
85%) 5 (100%) 7 (100%) 5 (100%)
%) 0 (0%) 0 (0%) 1 (33%)
r, arm, hypertension and diabetes
end-to-end, S-E side-to-end, S-S side-to-side
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calculated by pulsed-wave Doppler. This was used to
calculate the BFV with the assumptions and proced-
ure previously described [9, 15]. Standardization of
these examinations was performed according to model
requirements. During the follow-up DUS examination
at 40 days after surgery, diameter measurements of
brachial artery, radial artery and cephalic vein were
performed. During this examination TAV was also
assessed in brachial and radial artery and used to
calculate BFV with the same procedure used for pre-
operative examination.
Statistical analysis
Data are expressed as Mean ± SD. The correlation
between predicted and measured brachial artery BFV
was investigated using the linear regression analysis. The
agreement between predicted and measured BFV in
distal AVFs was analyzed using Bland-Altman plot.
Results
Data from 60 patients with newly created AVF were di-
vided into groups based on AVF configuration: lower
arm RC S-E (n = 32), lower arm RC E-E (n = 13), lower
arm RC S-S (n = 5), upper arm BC S-E (n = 7) and upper
arm BC S-S (n = 3). In general, a good agreement was
observed between predicted and measured brachial ar-
tery BFV at 40 days after surgery, with average values of
787 ± 306 vs. 751 ± 267 mL/min, respectively. As ex-
pected, regression analysis between predicted and mea-
sured values of brachial artery BFV showed a strong andFig. 3 Comparison between predicted and measured brachial artery BFV at
Abbreviations: BFV, blood flow volume; RC, radio-cephalic; S-E, side-to-endstatistically significant linear correlation in the whole
final dataset (R = 0.81, p < 0.001).
In patients with newly created RC S-E AVF, the
comparison between predicted and measured brachial
artery BFV is reported in Fig. 3, showing a good
accuracy of the simulations, with agreement between
predicted and measured brachial BFV (704 ± 186 vs.
720 ± 166 mL/min, respectively), with very good pre-
diction for some patients and some discrepancies in
only two of them. Similarly, in RC E-E and S-S AVF,
a good agreement was observed for E-E AVF between
predicted and measured BFV (755 ± 274 vs. 722 ±
267 mL/min), and even a better prediction for BFV
of S-S AVF (843 ± 383 vs. 804 ± 388 mL/min), as
shown in Fig. 4.
We found less accurate agreement between predicted
and measured results for proximal AVF (1065 ± 463 vs.
858 ± 438 mL/min), as shown in Fig. 5. Out of ten
patients, important discrepancies were observed in two
cases of S-E anastomosis and in one case of S-S config-
uration. For the limited number of proximal AVFs,
further statistical analysis was conducted on results of
distal AVFs only. The Bland-Altman plot, reported in
Fig. 6a, shows a good accuracy between predicted and
measured blood flow in distal AVF. The difference
between predicted and measured BFV are uniformly
distributed in the entire range of average brachial artery
BFV (see Fig. 6a). The precision of the computed predic-
tion is shown in Fig. 6b by the box-plot of relative
percent difference between predicted and measured
brachial BFV that averaged 1.98 ± 20.87%. For half of the40 days after AVF surgery in patients with lower arm RC S-E AVF.
Fig. 4 Comparison between predicted and measured brachial artery BFV at 40 days after AVF surgery in patients with lower arm RC E-E and S-S
AVF. Abbreviations: BFV, blood flow volume; RC, radio-cephalic; E-E, end-to-end; S-S, side-to-side
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range 86–121% (second and third quartiles).
The analysis of the data obtained through the ques-
tionnaires revealed that DUS vascular protocol was clear
and exhaustive (mean score 4.6) and vascular measure-
ments required by the protocol acceptable in the clinical
routine (4.4). The procedure used for data collection and
transmission was appropriate (4.7) and pre-operative
and follow-up forms were useful for data collection
(4.6). Results of simulations were provided with haste by
the Simulation Center (4.2), the content of results files
was clear and well organized (4.7) and was found to
include all the data of interest (4.5). As regards data
management, clinicians felt comfortable in receiving
simulations results via email (4.6) and they appreciated
to have the DMS as repository of all pre-operative data,Fig. 5 Comparison between predicted and measured brachial artery BFV at
S-S and BB S-S AVF. Abbreviations: BFV, blood flow volume; BC, brachio-cepsimulations results and follow-up data (4.4). In conclu-
sion, all the participants declared they were willing to
use the AVF.SIM system for AVF planning (4.6).
Discussion
In the present observational study we evaluated the
power of prediction of AVF.SIM system and its accept-
ance in the routine clinical setting. This new system
allowed the successful integration of the previously
developed computational model in a single procedure
that includes data collection and transfer, numerical
simulation management and data storage. The good
agreement between predicted and measured BFV at
40 days after surgery, both for distal and proximal AVF,
confirmed that also in routine clinical settings the
accuracy of prediction of the computational model is40 days after AVF surgery in patients with upper arm AVF, BC S-E, BC
halic; BB, brachio-basilic; S-E, side-to-end; S-S, side-to-side
Fig. 6 a Bland-Altman plot showing the agreement between predicted and measured brachial BFV at 40 days after AVF creation. Different symbols
denote different AVF configurations. b Box plot showing the percent ratio between predicted and measured brachial artery BFV in distal AVFs. The
grey box represents the second and third quartiles (range 86–121%, median 101%), the above whisker represents the maximum of data range
(153%) and the below whisker the minimum (57%). Abbreviations: BFV, blood flow volume; E-E, end-to-end; S-E, side-to-end; S-S, side-to-side
Bozzetto et al. BMC Medical Informatics and Decision Making  (2017) 17:26 Page 7 of 9satisfactory, as it was during model validation obtained
in a controlled clinical study. In particular, for distal
AVFs the predicted values we obtained are in average
very close to those measured (with an average difference
of 1.98 ± 20.87% between predicted and measured BFV).
Values of the difference between predicted and mea-
sured brachial BFV after maturation were within the
range of 86–121% in 50% of patients, and in the range
of 60–144% for 95% of cases.
As far as effective usability of the computational tool,
the complete sets of data collected and the feedback
provided by clinicians indicated that AVF.SIM system is
easy to use and well accepted in clinical routine, with a
limited additional workload for pre-operative examin-
ation by the clinicians. Actually the computed prediction
of patient-specific BFVs after VA maturation are ob-
tained using the AVF.SIM system on the basis of demo-
graphic information, clinical data and pre-operative DUS
measurements, that are today all standard of care for
patients in need of VA for HD treatment. Time required
to fill up the pre-operative form and send data to the
Simulation Center was estimated to extend the routine
vascular mapping of approximately 10–15 min only.
Pre-operative physical examination and DUS evaluation
currently recommended by international guidelines [16]
have several potential benefits, but only a system that
takes into account the complex interplay of demographic
and clinical factors, as well as vessel dimensions and
local BFV, could really help the surgeon in identifying
the best site for AVF placement, as well as in preventing
very low or very high BFV, likely associated with VA
complications. The establishment of effective usability of
AVF.SIM in the clinical environment is a significant step
forward allowing computer assisted clinical decision
making on type and location of AVF, as well as for theevaluation of potential risks for VA non maturation. The
development and validation of the computational model,
despite important simplifications on vascular structure
and function, allowed obtaining valuable patient-specific
results, without the need of more invasive and complex
procedures like pre-operative magnetic resonance im-
aging or angiography [17].
To date, few studies deal with prediction of AVF
outcome. Lok et al. [18] presented a scoring system to
stratify the patient’s risk for failure to mature, identify-
ing in advanced age, peripheral vascular disease, coron-
ary artery disease and white race the most significant
clinical predictors. The Lok’s model, however, does not
predict AVF outcome. In a recent study conducted by
Masengu et al. [19], there is only general indication that
female gender, lower arm and low radial artery BFV are
associated with AVF failure. However, there is no
general consensus on the criteria to select the type of
anastomosis for AVF and the only suggestion is to avoid
making AVF in vessels of small diameter [4], which
means general indication for risk of failure, with no
indication about the best AVF type and location for
individual patients.
The use of AVF.SIM system in six clinical centers is
the first attempt at introducing a predictive computa-
tional tool for AVF outcome in the clinical routine.
The ability to predict blood flow and diameter may
allow surgeons to identify the best site for placement
of an AVF, that likely results in adequate BFV, guid-
ing them in creating a different VA when the pre-
dicted flow at 40 days post operation is too low for
all potential AVF sites, or suggesting a more distal
site for AVF creation in case of predicted BFV very
high for an upper-arm AVF. Thus, the clinical use of
the present computational model potentially allows
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approach, advocated by nephrologists as the only
strategy to succeed in VA creation [20, 21].
We have to acknowledge that accuracy of predicted
BFV in proximal AVF is lower as compared with results
obtained in distal AVFs. Comparisons between predicted
and measured BFV in the brachial artery, that is
upstream and far from the anastomosis site for distal
AVFs, may minimize measurement inaccuracies related
to the presence of disturbed flows [22]. In line with this
observation, we can hypothesize that less accurate pre-
dictions of proximal AVF, as compared to distal AVFs,
may be due to the fact that DUS examinations after VA
maturation are more complex in proximal than in distal
AVF, due to the proximity of the location for BFV meas-
urement to the anastomosis. We also have to acknow-
ledge that the number of patients excluded due to
inconsistent or incomplete follow-up data is not negli-
gible. Although to a lesser extent, the presence of
disturbed flow at the anastomosis may affect the accur-
acy of BFV measurements also for distal AVF, resulting
in radial BFV higher than brachial BFV. This may ex-
plain discrepancies we found in follow-up data and may
justify our choice of excluding these patients from the
final dataset. Another limitation of our investigation that
may explain the inaccuracy of prediction in BFV after
VA maturation, is that we assumed a constant 40 days
time interval for AVF maturation for the whole patient
population. While this assumption may be reasonable
for most of cases, it could be erroneous for some of
them, like diabetic patients, who have slower VA matur-
ation [23]. Finally, the results of our usability test are
also limited, in some way, by the small number of AVFs
examined. However, the positive results we obtained
suggest that a more extensive clinical evaluation of
AVF.SIM is worth to perform. A larger, randomized and
prospective study may provide more extensive evaluation
of clinical efficacy of AVF.SIM, as well as on the po-
tential improvement of AVF outcome as compared to
conventional VA surgery planning.
Conclusions
The clinical test of AVF.SIM system confirmed the
accuracy of BFV predictions and established that the
system is easy to use and well accepted in clinical
routine. The use of this system to support selection of
the optimal surgery procedure could help perform more
efficient AVF planning, reducing non maturation events,
late failure rate, and very high VA blood flows at risk for
heart failure and steal syndrome. The use of the compu-
tational modeling, in addition to the currently performed
DUS evaluations, may allow reduction of economic costs
associated with VA dysfunction, as well as morbidity and
mortality of HD patients.Additional files
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